Organization | Ram Manohar Lohia Insitute of Medical Sciences

Ram Manohar Lohia Insitute of Medical Sciences Report issue

Academic/Hospital Phase 3 Phase 4

Founded: Lucknow India (2006)

Organization Overview

First Clinical Trial

2012

NCT01766323

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Now

Alternative names

Dr. Ram Manohar Lohia Hospital | Ram Manohar Lohia Institute of Medical Sciences, Lucknow

Active Ingredients

Drugs in Phase 4 Trials (1)

valaciclovir (Valtrex) (1 trial)

Drugs in Phase 3 Trials (1)

modafinil (provigil) (1 trial)

Drugs in Other Trials (7)

daclatasvir (daklinza) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

ledipasvir (Harvoni) (1 trial)

ribavirin (virazole) (1 trial)

sofosbuvir (sovaldi) (1 trial)

velpatasvir (Epclusa) (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Herpes Simplex (Phase 4)

Psychotic Disorders (Phase 4)

Schizophrenia (Phase 4)

Sleepiness (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 9